Tumor necrosis factor gene polymorphism and septic shock in surgical infection
- 1 August 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 28 (8), 2733-2736
- https://doi.org/10.1097/00003246-200008000-00008
Abstract
To evaluate the relationship of the genotype distribution of the tumor necrosis factor (TNF)-α polymorphism with regard to the plasma TNF-α concentration and the development of septic shock as well as mortality of infected patients in a surgical intensive care unit (SICU). A total of 112 postoperative critically ill infected patients were prospectively enrolled. SICU of a tertiary university-affiliated medical center. Patients who were consecutively admitted to the SICU because of surgical infection with sepsis. Blood sampling. Blood sample was obtained 24 hrs after intensive care unit (ICU) admission or within 2 hrs after the onset of septic shock to determine the plasma TNF-α level and to analyze the genotype of the biallelic polymorphism of the TNF-α. The allele frequency of the TNF2 in our infected ICU patients was 12%. Forty-two (37.5%) patients admitted fulfilled the criteria of septic shock during their ICU stay. Patients carrying the TNF2 allele were not more likely to develop septic shock, nor did they have a higher mortality rate. In the patients with septic shock, those carrying the TNF2 allele had a significantly higher mortality rate than those with the homozygous TNF1 genotype (92% vs. 62%, p In patients admitted to SICU with surgical infection, the frequency of TNF2 allele was higher than in the general population. SICU patients with TNF2 allele did not show a higher incidence of developing septic shock, nor was there a higher baseline TNF-α level after infection. However, once septic shock had developed, the mortality rate was higher in those patients carrying the TNF2 allele.Keywords
This publication has 19 references indexed in Scilit:
- Perioperative plasma concentrations of tumor necrosis factor-alpha and interleukin-6 in infected patientsCritical Care Medicine, 1996
- A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsisCritical Care Medicine, 1996
- Variation in the TNF-α promoter region associated with susceptibility to cerebral malariaNature, 1994
- Role of tumor necrosis factor-α in disease states and inflammationCritical Care Medicine, 1993
- Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humansCritical Care Medicine, 1992
- Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus.Proceedings of the National Academy of Sciences, 1990
- Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humansCritical Care Medicine, 1989
- Plasma tumor necrosis factor and mortality in critically ill septic patientsCritical Care Medicine, 1989
- Endotoxin‐Stimulated Human Monocyte Secretion of Interleukin 1, Tumour Necrosis Factor Alpha, and Prostaglandin E2 Shows Stable Interindividual DifferencesScandinavian Journal of Immunology, 1988
- Control of Cachectin (Tumor Necrosis Factor) Synthesis: Mechanisms of Endotoxin ResistanceScience, 1986